Evidence map›Paper›PMID 30804176›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Activation of GCN2 by the ribosomal P-stalk.

Alison J Inglis, Glenn R Masson, Sichen Shao, Olga Perisic, Stephen H McLaughlin, Ramanujan S Hegde, Roger L Williams

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Substrate Binding Relieves Autoinhibition of the Mammalian GCN2 Kinase.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  13. Article
  14. Article
  15. Structural basis for pseudokinase-mediated regulation of GCN2 in the integrated stress response.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  16. Quality control and signaling pathways at stalled ribosomes.Experimental & molecular medicine · 2026
    Review
  17. Review
  18. Review
  19. GCN2 regulates paclitaxel-induced neuropathic pain.British journal of pharmacology · 2025
    Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alison J InglisMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Glenn R MassonMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0002-1386-4719
Sichen ShaoMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Olga PerisicMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Stephen H McLaughlinMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Ramanujan S HegdeMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Roger L WilliamsMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom rlw@mrc-lmb.cam.ac.uk.ORCID 0000-0001-7754-4207

Funding

Medical Research Council MC_U105184308Medical Research Council MC_UP_A022_1007
6 · The paper itself

Abstract

Cells dynamically adjust their protein translation profile to maintain homeostasis in changing environments. During nutrient stress, the kinase general control nonderepressible 2 (GCN2) phosphorylates translation initiation factor eIF2α, initiating the integrated stress response (ISR). To examine the mechanism of GCN2 activation, we have reconstituted this process in vitro, using purified components. We find that recombinant human GCN2 is potently stimulated by ribosomes and, to a lesser extent, by tRNA. Hydrogen/deuterium exchange-mass spectrometry (HDX-MS) mapped GCN2-ribosome interactions to domain II of the uL10 subunit of the ribosomal P-stalk. Using recombinant, purified P-stalk, we showed that this domain of uL10 is the principal component of binding to GCN2; however, the conserved 14-residue C-terminal tails (CTTs) in the P1 and P2 P-stalk proteins are also essential for GCN2 activation. The HisRS-like and kinase domains of GCN2 show conformational changes upon binding recombinant P-stalk complex. Given that the ribosomal P-stalk stimulates the GTPase activity of elongation factors during translation, we propose that the P-stalk could link GCN2 activation to translational stress, leading to initiation of ISR.

Indexed as

Amino Acid MotifsEukaryotic Initiation Factor-2HumansPhosphorylationProtein DomainsProtein Serine-Threonine KinasesRibosomesStructure-Activity RelationshipEIF2AK4 protein, humanEukaryotic Initiation Factor-2Protein Serine-Threonine KinasesGCN2HDX-MSP-stalkribosome stallinguL10/P1/P2

Identifiers

PMID30804176
PMCPMC6421407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.